The biopharmaceutical company received FDA approval for a first-of-its-kind treatment for a rare neurodevelopmental disease.

Only 37% of baby boomers express certainty they can handle future financial needs, and younger generations are even less sure ...

Salesforce stood by its long-term growth targets and argued it can withstand the AI boom at its annual Dreamforce conference.

Goldman Sachs Group stock has been the worst performer of big banks lately and came under renewed pressure after comments ...

Clarity on how much revenue Tempus AI TEM +14.50% will bring in through Medicare reimbursements for two of its cancer ...

Snap is bringing SPECS Intelligence to its smart glasses, iPhones, and Macs as competition in consumer AI intensifies.

U.S.-listed Nokia shares rise after the company announces it has extended its relationship with Microsoft to advanced AI ...

The paper losses on a large Bank of America bond portfolio could have widened by more than $10 billion to over $90 billion in ...

Federal Reserve Chairman Kevin Warsh and Treasury Secretary Scott Bessent are at odds over how to manage the benchmark ...

Bitcoin remains well-positioned to target the $125,000 area by early 2027, technical analysis shows. The stock is poised to ...

Fluence Energy cut its fiscal-year revenue forecast as production delays and logistical problems disrupt its new Houston ...

The stock is poised to gain 20% by early 2027, judging by technical indicators. Shares of the sneaker maker are trading ...